EXAS: A Biotech Stock Screening to Prevent Colorectal Cancer

Exact Sciences Corporation EXAS is a biotechnology firm focused on using molecular diagnostics to screen for cancer and identify candidates who may be at a higher risk of getting cancer.  The company was founded in 1995, and it has